<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03943849</url>
  </required_header>
  <id_info>
    <org_study_id>HSC-DB-18-0873</org_study_id>
    <nct_id>NCT03943849</nct_id>
  </id_info>
  <brief_title>The Use of Dental Pulp Tissue as an Autogenous Graft for Ridge Augmentation</brief_title>
  <official_title>The Use of Dental Pulp Tissue as an Autogenous Graft for Ridge Augmentation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine and compare the effects of autogenous dental pulp&#xD;
      tissue on bone formation in the extraction sockets as compared to commonly used particulate&#xD;
      bone graft. The effects on bone formation will be examined using a wide variety of assays.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2023</start_date>
  <completion_date type="Anticipated">September 1, 2025</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bone fill as assessed by radiograph</measure>
    <time_frame>immediately after placement of bone graft</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Bone fill as assessed by radiograph</measure>
    <time_frame>2 months after placement of bone graft</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Bone fill as assessed by radiograph</measure>
    <time_frame>4 months after placement of bone graft</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Extent of mineralization as assessed by von Kossa staining</measure>
    <time_frame>4 months after placement of bone graft</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Extent of mineralization as assessed by Xylenol Orange staining</measure>
    <time_frame>4 months after placement of bone graft</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Expression of osteoblastic marker Bsp assessed by quantitative PCR (qPCR)</measure>
    <time_frame>4 months after placement of bone graft</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Expression of osteoblastic marker BSP assessed by immunostaining using anti-BSP antibody</measure>
    <time_frame>4 months after placement of bone graft</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Expression of osteoblastic marker Bglap assessed by quantitative PCR (qPCR)</measure>
    <time_frame>4 months after placement of bone graft</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Expression of osteoblastic marker BGLAP assessed by immunostaining using anti-BGLAP antibody</measure>
    <time_frame>4 months after placement of bone graft</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Expression of osteoblastic marker Dmp1 assessed by quantitative PCR (qPCR)</measure>
    <time_frame>4 months after placement of bone graft</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Expression of osteoblastic marker DMP1 assessed by immunostaining using anti-DMP1 antibody</measure>
    <time_frame>4 months after placement of bone graft</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Expression of osteoblastic marker Col1a1 assessed by quantitative PCR (qPCR)</measure>
    <time_frame>4 months after placement of bone graft</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Expression of osteoblastic marker Sost assessed by quantitative PCR (qPCR)</measure>
    <time_frame>4 months after placement of bone graft</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Tooth Loss</condition>
  <arm_group>
    <arm_group_label>Particulate bone graft plus autogenous dental pulp tissue</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dental pulp will be isolated from teeth extracted for non-periodontal reasons chairside. The isolated dental pulp will be mixed with hydrated particulate bone graft, and the mixture will be placed in the debrided extraction socket. The socket will be covered by a resorbable collagen membrane and sutured.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Particulate bone graft</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Hydrated particulate bone graft will be placed in the debrided extraction socket. The socket will be covered by a resorbable collagen membrane and sutured.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Particulate bone graft</intervention_name>
    <description>Creos allo.gain allogenic bone particulate mineralized cortical bone will be hydrated and placed in the extraction socket.</description>
    <arm_group_label>Particulate bone graft</arm_group_label>
    <arm_group_label>Particulate bone graft plus autogenous dental pulp tissue</arm_group_label>
    <other_name>creos allo.gain</other_name>
    <other_name>allogenic bone particulates</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Autogenous dental pulp tissue</intervention_name>
    <description>Dental pulp will be isolated from teeth extracted for non-periodontal reasons chairside, mixed with hydrated particulate bone graft, and then placed in the extraction socket.</description>
    <arm_group_label>Particulate bone graft plus autogenous dental pulp tissue</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Resorbable collagen membrane</intervention_name>
    <description>After placement of particulate bone graft or particulate bone graft plus autogenous dental pulp tissue, socket will be covered by a resorbable collagen membrane and sutured.</description>
    <arm_group_label>Particulate bone graft</arm_group_label>
    <arm_group_label>Particulate bone graft plus autogenous dental pulp tissue</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Suture</intervention_name>
    <description>Resorbable or non-resorbable suture material</description>
    <arm_group_label>Particulate bone graft</arm_group_label>
    <arm_group_label>Particulate bone graft plus autogenous dental pulp tissue</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  American Society of Anesthesiologists (ASA) Physical Status Classification System ASA&#xD;
             1 (A normal healthy patient) or ASA 2 (A patient with mild systemic disease)&#xD;
&#xD;
          -  never smoker&#xD;
&#xD;
          -  patients with planned tooth extraction&#xD;
&#xD;
          -  intact extraction sockets&#xD;
&#xD;
          -  no medication or antibiotics intake for at least 6 months prior to the procedure&#xD;
&#xD;
          -  patients who gave their consent to participate in the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  vulnerable subjects (children, pregnant and lactating women, patients with learning&#xD;
             disabilities, and prisoners)&#xD;
&#xD;
          -  inability to obtain pulp tissue (for example, due to previous endodontic therapy,&#xD;
             obliterated pulp canals)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karo Parsegian, DMD, MDSc, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas Health Science Center, Houston</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Karo Parsegian, DMD, MDSc, PhD</last_name>
    <phone>713-486-4087</phone>
    <email>Karo.Parsegian@uth.tmc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>The University of Texas Health Science Center at Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>May 7, 2019</study_first_submitted>
  <study_first_submitted_qc>May 7, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 9, 2019</study_first_posted>
  <last_update_submitted>October 21, 2021</last_update_submitted>
  <last_update_submitted_qc>October 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Texas Health Science Center, Houston</investigator_affiliation>
    <investigator_full_name>Karo Parsegian</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Bone graft</keyword>
  <keyword>Tooth extraction</keyword>
  <keyword>Dental pulp</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tooth Loss</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

